Under the terms of the agreement, Oncolytics has the right to sell, and Alumni has the obligation to purchase up to US$20 ...

D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...

D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted ...

As I See It,” a weekly photo column by Pulitzer Prize winner Stan Grossfeld, brings the stories of New England to Globe ...

By the start of the year, that idea had morphed into a biotech hopeful known as Opthea ... Based in Melbourne’s South Yarra with a marketing logo promising the “Gift of Sight”, Baldwin ...

Global business visionary, inventor, and philanthropist leaves behind a legacy of improving billions of lives around the ...

Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of therapies for ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

SYNT-101 offers a novel approach to weight loss by temporarily altering nutrient absorption in the small intestine. Unlike GLP-1 drugs, which are administered via injection and ...

Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on PRTG: Disclaimer & Disclosure Report an Issue Portage Biotech NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

Terms While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors.